Seeking Alpha

  Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ

PGNX vs. ETF Alternatives
Company Description
Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology .It develops products for the treatment of prostate cancer, for the treatment of opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
Sector: Healthcare
Industry: Biotechnology
Country: United States